GlassScriptPhysician profile
Lillian R Awar
NPI 1932162187
$1,634.52
in general payments reported to CMS, 2019-2025
16 companies · $795 in 2025
The $795 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $69.38 · 2023: $98.84 · 2024: $548 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $211.83 | 2024 | Voquezna |
| Neurocrine Biosciences, INC. | $211.13 | 2021-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $207.53 | 2022-2025 | Caplyta |
| Biomerieux INC | $162.00 | 2025 | |
| Lundbeck LLC | $158.63 | 2022-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Alexion Pharmaceuticals, INC. | $117.83 | 2025 | |
| Axsome Therapeutics, INC. | $100.68 | 2025 | Symbravo |
| Teva Pharmaceuticals USA, INC. | $81.76 | 2024-2025 | Uzedy |
| Globus Medical, INC. | $73.83 | 2025 | Senza |
| Otsuka America Pharmaceutical, INC. | $72.41 | 2025 | Abilify Asimtufii, Rexulti |
| Alkermes, INC. | $54.17 | 2021-2023 | Aristada, Lybalvi |
| Neurelis, INC. | $50.58 | 2024 | Valtoco |
| Abbvie INC. | $47.11 | 2021-2024 | |
| Exact Sciences Corporation | $32.58 | 2025 | The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $29.47 | 2024 | Invega Sustenna |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $22.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Awar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.